Q4 2024 13F Holders as of 12/31/2024
-
Type / Class
-
Equity / Common Stock, par value $0.001 per share
-
Shares outstanding
-
62.5M
-
Number of holders
-
336
-
Total 13F shares, excl. options
-
67.1M
-
Shares change
-
+2.09M
-
Total reported value, excl. options
-
$5.85B
-
Value change
-
+$180M
-
Put/Call ratio
-
0.87
-
Number of buys
-
187
-
Number of sells
-
-124
-
Price
-
$87.22
Significant Holders of Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) as of Q4 2024
394 filings reported holding BPMC - Blueprint Medicines Corp - Common Stock, par value $0.001 per share as of Q4 2024.
Blueprint Medicines Corp - Common Stock, par value $0.001 per share (BPMC) has 336 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67.1M shares
.
Largest 10 shareholders include BlackRock, Inc. (6.87M shares), VANGUARD GROUP INC (6.77M shares), PRICE T ROWE ASSOCIATES INC /MD/ (5.68M shares), WELLINGTON MANAGEMENT GROUP LLP (4.28M shares), STATE STREET CORP (2.5M shares), FMR LLC (2.25M shares), WILLIAM BLAIR INVESTMENT MANAGEMENT, LLC (1.94M shares), GEODE CAPITAL MANAGEMENT, LLC (1.49M shares), MACQUARIE GROUP LTD (1.26M shares), and Avoro Capital Advisors LLC (1.19M shares).
This table shows the top 336 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.